Premium
Dose increase of imatinib mesylate may overcome acquired resistance in bcr/abl‐positive acute lymphoid leukaemia
Author(s) -
Piccaluga Pier Paolo,
Malagola Michele,
Rondoni Michela,
Amabile Marilina,
Paolini Stefania,
Soverini Simona,
Gaitani Stavroula,
Visani Giuseppe,
Baccarani Michele,
Martinelli Giovanni
Publication year - 2004
Publication title -
european journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 84
eISSN - 1600-0609
pISSN - 0902-4441
DOI - 10.1111/j.1600-0609.2004.00212.x
Subject(s) - hematology , medicine , imatinib mesylate , oncology , imatinib , myeloid leukemia